Research Reports Coverage on Health Care Plans Stocks -- Aetna, Centene, Humana, and Anthem

Tuesday, February 28, 2017 Research News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, February 28, 2017 /PRNewswire/ -- has initiated coverage on these Health Care Plans stocks:

Aetna Inc. (NYSE: AET), Centene Corp. (NYSE: CNC), Humana Inc. (NYSE: HUM), and Anthem Inc. (NYSE: ANTM). These companies offer health benefit plans to employers and individuals who require long-term care or specialty benefits, point-of-service plans,
traditional indemnity plans, and other hybrid plans. These stocks research reports can be downloaded now by simply registering for free at:


On Monday, shares in Connecticut-based Aetna Inc. recorded a trading volume of 2.37 million shares. The stock ended the session 0.38% higher at $129.46. The Company's shares have gained 10.05% in the last one month, 0.30% in the previous three months, and 4.61% on an YTD basis. The stock is trading 5.05% above its 50-day moving average and 9.23% above its 200-day moving average. Moreover, shares of Aetna, which operates as a health care benefits company in the US, have a Relative Strength Index (RSI) of 62.89.

On February 27th, 2017, Aetna announced that it will redeem for cash the entire $750 million aggregate principal amount outstanding of its 3.95 percent Senior Notes due September 01st, 2020, on or about March 29th, 2017. The 2020 Notes will be redeemed at a redemption price that includes a make-whole premium, plus any interest accrued and unpaid to, but excluding, the redemption date. Aetna expects to fund the redemption from available cash and short-term debt. Your complete research report on AET can be retrieved for free at:


Missouri headquartered Centene Corp.'s stock closed the day 0.71% higher at $71.11 with a total trading volume of 1.48 million shares. The Company's shares have advanced 12.00% in the past month, 26.06% over the previous three months, and 25.84% since the start of this year. The stock is trading 12.75% and 10.42% above its 50-day and 200-day moving averages, respectively. Additionally, shares of Centene, which operates as a diversified and multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the US, have an RSI of 67.28.

On February 08th, 2017, research firm Barclays reiterated its 'Overweight' rating on the Company's stock with an increase of the target price from $75 a share to $79 a share.

On February 20th, 2017, Centene announced the appointment of former Missouri Attorney General Chris Koster to Senior Vice President, Corporate Services effective immediately. Mr. Koster will report directly to Chairman, President, and CEO Michael F. Neidorff, and will assist in business-related issues, outside of Government Relations, for Centene's locally-based health plans across the country. A free report on CNC is just a click away at:


Shares in Kentucky headquartered Humana Inc. recorded a trading volume of 1.34 million shares, and ended yesterday's trading session 0.71% higher at $208.75. The stock has advanced 4.31% in the past month, 0.54% in the previous three months, and 2.46% on an YTD basis. The Company's shares are trading above their 50-day and 200-day moving averages by 3.01% and 12.84%, respectively. Furthermore, shares of Humana, which together with its subsidiaries, operates as a health and well-being company in the US, have an RSI of 58.65.

On February 16th, 2017, Caravan Health and Humana announced that Humana Medicare Advantage members in Kansas, Missouri, Arkansas, and Oklahoma will have more access to a health care model known as value-based care through a new relationship between the companies. The arrangement is designed to offer Humana Medicare members a proactive and wellness-focused health care experience and financially reward doctors for high quality care. Humana Medicare Advantage members will have access to more than 300 Caravan Health primary care providers in the four states. Sign up for your complimentary research report on HUM at:


Indiana headquartered Anthem Inc.'s stock finished Monday's session 0.66% higher at $164.91 with a total trading volume of 1.46 million shares. The Company's shares have advanced 8.21% in the last one month, 15.35% over the previous three months, and 14.70% since the start of this year. The stock is trading above its 50-day and 200-day moving averages by 8.51% and 22.08%, respectively. Additionally, shares of Anthem, which through its subsidiaries, operates as a health benefits company in the US, have an RSI of 66.18.

On February 02nd, 2017, research firm RBC Capital Markets reiterated its 'Outperform' rating on the Company's stock with an increase of the target price from $169 a share to $174 a share.

On February 22nd, 2017, Anthem announced that its Audit Committee declared a dividend of $0.65 per share for Q1 FY17. This quarterly rate represents an annualized dividend of $2.60 per share. The dividend is payable on March 24th, 2017, to shareholders of record at the close of business on March 10th, 2017. Register for free on and download the latest research report on ANTM at:

Stock Callers: 

Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

SC has not been compensated; directly or indirectly; for producing or publishing this document. 


The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email . Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.


SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 


This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: Phone number:  +44-330-808-3765 Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Chelmsford Park SA


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store